Association of women-specific health factors in the severity of Parkinson's disease.


Journal

NPJ Parkinson's disease
ISSN: 2373-8057
Titre abrégé: NPJ Parkinsons Dis
Pays: United States
ID NLM: 101675390

Informations de publication

Date de publication:
05 Jun 2023
Historique:
received: 17 10 2022
accepted: 15 05 2023
medline: 6 6 2023
pubmed: 6 6 2023
entrez: 5 6 2023
Statut: epublish

Résumé

Parkinson's disease (PD) is an age-related neurological disorder known for the observational differences in its risk, progression, and severity between men and women. While estrogen has been considered to be a protective factor in the development of PD, there is little known about the role that fluctuations in hormones and immune responses from sex-specific health experiences have in the disease's development and severity. We sought to identify women-specific health experiences associated with PD severity, after adjusting for known PD factors, by developing and distributing a women-specific questionnaire across the United States and creating multivariable models for PD severity. We created a questionnaire that addresses women's specific experiences and their PD clinical history and deployed it through The Parkinson's Foundation: PD Generation. To determine the association between women-specific health factors and PD severity, we constructed multivariable logistic regression models based on the MDS-UPDRS scale and the participants' questionnaire responses, genetics, and clinical data. For our initial launch in November 2021, we had 304 complete responses from PD GENEration. Univariate and multivariate logistic modeling found significant associations between major depressive disorder, perinatal depression, natural childbirth, LRRK2 genotype, B12 deficiency, total hysterectomy, and increased PD severity. This study is a nationally available questionnaire for women's health and PD. It shifts the paradigm in understanding PD etiology and acknowledging how sex-specific experiences may contribute to PD severity. In addition, the work in this study sets the foundation for future research to investigate the factors behind sex differences in PD.

Identifiants

pubmed: 37277346
doi: 10.1038/s41531-023-00524-x
pii: 10.1038/s41531-023-00524-x
pmc: PMC10241917
doi:

Types de publication

Journal Article

Langues

eng

Pagination

86

Informations de copyright

© 2023. The Author(s).

Références

Ageing Res Rev. 2020 Sep;62:101093
pubmed: 32502628
Neurology. 2020 Mar 17;94(11):481-494
pubmed: 32102975
Mov Disord Clin Pract. 2020 Apr 09;7(4):419-430
pubmed: 32373659
Front Glob Womens Health. 2021 Oct 07;2:742775
pubmed: 34816246
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1272-1277
pubmed: 27514583
Parkinsonism Relat Disord. 2017 Jul;40:11-17
pubmed: 28506531
Parkinsonism Relat Disord. 2014 Aug;20(8):911-4
pubmed: 24816003
Am J Pharm Educ. 2008 Apr 15;72(2):43
pubmed: 18483608
Nutrients. 2019 Feb 13;11(2):
pubmed: 30781902
Neurology. 1999 Apr 22;52(7):1417-21
pubmed: 10227628
Neurochem Res. 2012 Jul;37(7):1436-41
pubmed: 22367474
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
PLoS One. 2018 Aug 23;13(8):e0202755
pubmed: 30138406
Front Aging Neurosci. 2018 Sep 19;10:283
pubmed: 30283330
CMAJ. 2016 Nov 1;188(16):1157-1165
pubmed: 27221269
Mov Disord. 2015 Oct;30(12):1632-8
pubmed: 25649812
Front Neuroendocrinol. 2012 Apr;33(2):169-78
pubmed: 22387674
Genet Med. 2020 Mar;22(3):574-580
pubmed: 31680121
Parkinsonism Relat Disord. 2010 Nov;16(9):576-81
pubmed: 20674460
Dtsch Arztebl Int. 2008 Oct;105(40):680-5
pubmed: 19623286
Neuroepidemiology. 2016;46(4):292-300
pubmed: 27105081
Mov Disord. 2001 Sep;16(5):830-7
pubmed: 11746612
Arch Womens Ment Health. 2019 Apr;22(2):289-299
pubmed: 30008085
Nat Neurosci. 2017 Feb;20(2):287-296
pubmed: 27991897
J Parkinsons Dis. 2020;10(s1):S29-S36
pubmed: 32651336
J Neurol. 2005 Oct;252(10):1201-5
pubmed: 16151602
Eur J Neurol. 2021 Jun;28(6):2054-2064
pubmed: 33619867
Fertil Steril. 2013 Apr;99(5):1324-1331.e1
pubmed: 23290741
Arch Neurol. 1989 Oct;46(10):1052-60
pubmed: 2508608
NPJ Parkinsons Dis. 2020 Apr 8;6:7
pubmed: 32284961
NPJ Parkinsons Dis. 2021 Mar 3;7(1):21
pubmed: 33658517
Stat Med. 2002 Aug 30;21(16):2409-19
pubmed: 12210625
J Parkinsons Dis. 2022;12(1):153-171
pubmed: 34776419
Int Psychogeriatr. 2012 Apr;24(4):541-56
pubmed: 22221769
Mov Disord. 2009 Jul 15;24(9):1359-65
pubmed: 19424986
Endocrine. 2006 Apr;29(2):243-56
pubmed: 16785600
Obstet Gynecol. 2000 Jun;95(6 Pt 1):861-6
pubmed: 10905922
Arch Neurol. 2004 Jun;61(6):886-8
pubmed: 15210525
Lancet. 2021 Jun 12;397(10291):2284-2303
pubmed: 33848468
Mov Disord. 2022 May;37(5):1112-1113
pubmed: 35587626
Mov Disord. 2012 Oct;27(12):1513-21
pubmed: 23079770
J Neurol Sci. 2012 Dec 15;323(1-2):33-9
pubmed: 22935408
Front Neurol. 2015 Sep 01;6:191
pubmed: 26388833
PLoS One. 2014 Oct 17;9(10):e108982
pubmed: 25330404
Neurosci Lett. 2020 Jan 10;715:134609
pubmed: 31698024
Mov Disord. 2022 Mar;37(3):444-455
pubmed: 35060180
PLoS One. 2015 Jul 14;10(7):e0133002
pubmed: 26171861
Parkinsonism Relat Disord. 2015 Jan;21(1):50-4
pubmed: 25466406
Gend Med. 2011 Jun;8(3):209-17
pubmed: 21664587
J Clin Mov Disord. 2020 Mar 12;7:3
pubmed: 32257364
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
J Gen Intern Med. 2005 Jan;20(1):45-51
pubmed: 15693927
Curr Neuropharmacol. 2018;16(9):1348-1357
pubmed: 29473513
Horm Behav. 2013 Feb;63(2):308-14
pubmed: 22687345
Genes (Basel). 2021 Mar 29;12(4):
pubmed: 33805527
Mov Disord. 2019 Oct;34(10):1480-1487
pubmed: 31291488
Obstet Gynecol. 2007 Nov;110(5):1091-5
pubmed: 17978124
J Neurosci. 2019 Sep 18;39(38):7628-7640
pubmed: 31405930
Front Neuroendocrinol. 2018 Jul;50:18-30
pubmed: 28974386
Ann Clin Transl Neurol. 2017 Oct 19;4(11):801-810
pubmed: 29159192
Neurology. 2005 Aug 9;65(3):383-90
pubmed: 16087902
Mov Disord. 2017 Sep;32(9):1330-1331
pubmed: 28657124
Neuropsychiatr Dis Treat. 2014 Dec 31;11:59-66
pubmed: 25657580
J Obstet Gynecol Neonatal Nurs. 2016 Sep-Oct;45(5):749-56
pubmed: 27444842
Obstet Gynecol. 2013 Aug;122(2 Pt 1):233-241
pubmed: 23969789
PLoS Med. 2018 Jan 23;15(1):e1002494
pubmed: 29360829
Am J Ind Med. 2019 Sep;62(9):766-776
pubmed: 31328814
Front Neurosci. 2020 Mar 10;14:157
pubmed: 32210745
Mov Disord. 2021 Oct;36(10):2264-2272
pubmed: 34426982
Mov Disord. 2014 Jun;29(7):889-96
pubmed: 24352877
BMJ Glob Health. 2016 Nov 1;1(3):e000080
pubmed: 28588958
J Parkinsons Dis. 2019;9(3):501-515
pubmed: 31282427
Am J Obstet Gynecol. 2008 Jan;198(1):34.e1-7
pubmed: 17981254
Neurology. 2009 Oct 27;73(17):1381-7
pubmed: 19858460
Parkinsonism Relat Disord. 2013 Apr;19(4):457-60
pubmed: 23402992
Maturitas. 2010 Apr;65(4):352-8
pubmed: 20117891
J Am Geriatr Soc. 2012 Jun;60(6):1057-63
pubmed: 22690982
JAMA Neurol. 2018 Mar 1;75(3):312-319
pubmed: 29309488
Neurology. 2008 Jan 15;70(3):200-9
pubmed: 17761549
NPJ Parkinsons Dis. 2021 Jan 21;7(1):10
pubmed: 33479241
Psychoneuroendocrinology. 2020 Feb;112:104507
pubmed: 31757430

Auteurs

Shilpa C Rao (SC)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Yadi Li (Y)

Center for Outcomes Research and Evaluation, Cleveland Clinic, Cleveland, OH, USA.
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.

Brittany Lapin (B)

Center for Outcomes Research and Evaluation, Cleveland Clinic, Cleveland, OH, USA.
Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.

Sreya Pattipati (S)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Kamalini Ghosh Galvelis (K)

Parkinson's Foundation, New York, USA.

Anna Naito (A)

Parkinson's Foundation, New York, USA.

Nicolas Gutierrez (N)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Thiago Peixoto Leal (TP)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Amira Salim (A)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Philippe A Salles (PA)

Center for Movement Disorders CETRAM, University of Santiago de Chile, Santiago, Chile.

Maria De Leon (M)

DefeatParkinsons, Houston, TX, USA.
De Leon Enterprises, Houston, TX, USA.

Ignacio F Mata (IF)

Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, USA. MATAI@ccf.org.
Department of Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA. MATAI@ccf.org.

Classifications MeSH